Welcome to medications.com
Ligand Pharmaceuticals shares slide on 4Q results - CNNMoney.com
In 2008, Ligand said it expects to receive roughly $20 million in royalty revenue from King Pharmaceuticals (NYSE:KG) for sales of Avinza and potential ...
http://money.cnn.com/news/newsfee... |
Posted: Thu Feb 21 14:56:27 -0500 2008
Avinza RSS FeedFrequently Reported Side Effects of Avinza
© 2002-2007, Skylabs Inc. |
About Us |
Disclaimer/Terms of Use |
Advertise |
Contact Us |
Site Map |
Developed by:
W3matter.com
